Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07033728

The Health of Women Monitored in the Addiction Department of the Strasbourg University Hospitals

The health of women suffering from addiction is little known and little explored in the literature. Indeed, they represent only 20% of addicted patients in general and are encountered primarily during pregnancy or complex situations involving young children.

In the Addiction Department of Strasbourg University Hospitals, the investigators have established a midwifery consultation exclusively for women of all ages.

During the treatment of the women, the investigators were able to identify the specific issues faced by women suffering from addiction and the specific care requirements for this population.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Service d'addictologie - CHU de Strasbourg - France

Strasbourg, 67091, France

Location status: Recruiting

Location contact

Cécile NORTH, Midwife

CONTACT

[email protected]

33 3 88 11 51 62

Cécile NORTH, Midwife

PRINCIPAL_INVESTIGATOR

Laurence LALANNE, MD, PhD

CONTACT

[email protected]

33 3 88 11 64 25

Laurence LALANNE, MD, PhD

SUB_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female, adult (≥ 18 years old)
  • Undergoing follow-up at the CSAPA Addictions Department of the HUS
  • Having met the team's midwife at least once
  • Absence of written objection in the patient's medical record regarding the reuse of her data for scientific research purposes.

Exclusion criteria

  • Absence of written objection in the patient's medical record regarding the reuse of her data for scientific research purposes
  • Female minor
  • Female who has not initiated follow-up with the CSAPA team
  • Women who have never had a consultation with the team's midwife

Treatment and study plan

Primary outcomes

  1. Rate of gynecological follow-up regardless of age compared to the general population

    Time frame: Up to 18 months

    This is a retrospective study to carry out an inventory of the health status of women treated at the CSAPA (Center for Addiction Care, Support, and Prevention) of the HUS (University Hospitals of Strasbourg)

Secondary outcomes

  1. Rate of Consumption of toxic drugs compared to the general population

    Time frame: Up to 18 months

    This is a retrospective study to carry out an inventory of the health status of women treated at the CSAPA (Center for Addiction Care, Support, and Prevention) of the HUS (University Hospitals of Strasbourg)

  2. Rate of sexual violence compared to the general population

    Time frame: Up to 18 months

    This is a retrospective study to carry out an inventory of the health status of women treated at the CSAPA (Center for Addiction Care, Support, and Prevention) of the HUS (University Hospitals of Strasbourg)

Study contacts

Contact information is provided by the study sponsor or research team.

Cécile NORTH, Midwife

CONTACT

[email protected]

33 3 88 11 51 62

Laurence LALANNE, MD, PhD

CONTACT

[email protected]

33 3 88 11 64 25

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Acronym: Santé-Fem

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jun 24, 2025
Registry last updated
Jun 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.